Shopping Cart
Remove All
Your shopping cart is currently empty
Paridiprubart (Synonyms: NI-0101, NI0101)
Catalog No. T74427 Copy Product Info
Purity: 95%
🥰Excellent
Paridiprubart (NI-0101) is a humanised monoclonal antibody targeting TLR4, demonstrating ameliorative effects in COVID-19 patients with acute respiratory distress syndrome (ARDS) and holding potential for rheumatoid arthritis research.
Paridiprubart
Copy Product Info🥰Excellent
Catalog No. T74427
Synonyms NI-0101, NI0101
Paridiprubart (NI-0101) is a humanised monoclonal antibody targeting TLR4, demonstrating ameliorative effects in COVID-19 patients with acute respiratory distress syndrome (ARDS) and holding potential for rheumatoid arthritis research.
Paridiprubart
Cas No. 2641646-59-3
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $158 | - | In Stock | |
| 5 mg | $396 | - | In Stock | |
| 10 mg | $645 | - | In Stock | |
| 25 mg | $997 | - | In Stock | |
| 50 mg | $1,330 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:96.9% (SDS-PAGE); 98.5% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Paridiprubart (NI-0101) is a humanised monoclonal antibody targeting TLR4, demonstrating ameliorative effects in COVID-19 patients with acute respiratory distress syndrome (ARDS) and holding potential for rheumatoid arthritis research. |
| In vitro | In rheumatoid arthritis (RA) patients, monocytes pretreated with Paridiprubart (20 μg/mL for 30 minutes) significantly inhibited proinflammatory cytokine production induced by rheumatoid arthritis synovial fluid (RASF) [1]. Paridiprubart suppressed TNF-α secretion in macrophages stimulated by citrus limon acidified fibrinogen immune complexes (cFb-IC) through an Fc-dependent pathway [1]. |
| Synonyms | NI-0101, NI0101 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TLR4 |
| Molecular Weight | 145.16 kDa |
| Cas No. | 2641646-59-3 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Paridiprubart | purchase Paridiprubart | Paridiprubart cost | order Paridiprubart | Paridiprubart in vitro | Paridiprubart molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.